文献速递头颈CT

基于对比增强计算机断层扫描的机器学习影像组学预测头颈部鳞状细胞癌IDH1表达及临床预后

Contrast-Enhanced Computed Tomography-Based Machine Learning Radiomics Predicts IDH1 Expression and Clinical Prognosis in Head and Neck Squamous Cell Carcinoma.
PubMed 文献 · Acad Radiol · 2024-09-10

本研究利用癌症基因组图谱和癌症影像档案的基因组、临床病理及对比增强CT图像数据,构建预测头颈部鳞状细胞癌IDH1表达的影像组学模型并分析其预后意义。IDH1表达是显著预后因素(HR 1.535,95%CI 1.117-2.11,P=0.008);基于8个最优特征的影像组学模型在训练集和验证集预测IDH1表达的AUC分别为0.848和0.779;影像组学评分与总生存显著相关(HR=2.22,95%CI 1.026-4.805,P=0.043)。

要点

  • 基于8个最优特征的对比增强CT影像组学模型可预测HNSCC的IDH1表达,训练集AUC 0.848、验证集AUC 0.779。
  • IDH1表达是HNSCC的独立预后因素,风险比HR 1.535(95%CI 1.117-2.11,P=0.008)。
  • 影像组学评分与总生存显著相关,HR=2.22(95%CI 1.026-4.805,P=0.043)。

核心结论

  • IDH1表达是显著的预后标志物;基于对比增强CT特征的影像组学模型为HNSCC的诊断和预后评估提供了有前景的方法。

研究设计与样本

  • 利用癌症基因组图谱和癌症影像档案的基因组数据、临床病理特征及对比增强CT图像进行预后分析和影像组学模型构建;采用组内相关系数、最小冗余最大相关性和递归特征消除算法筛选最优特征,使用梯度提升机构建IDH1预测影像组学模型和影像组学评分。

诊断标准与关键数值

  • 影像组学模型基于8个最优特征预测IDH1表达水平,训练集AUC为0.848、验证集AUC为0.779;校准曲线和决策曲线分析验证了模型的适用性和临床实用性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Isocitrate dehydrogenase 1 (IDH1) is a potential therapeutic target across various tumor types. Here, we aimed to devise a radiomic model capable of predicting the IDH1 expression levels in patients with head and neck squamous cell carcinoma (HNSCC) and examined its prognostic significance.

MATERIALS AND METHODS: We utilized genomic data, clinicopathological features, and contrast-enhanced computed tomography (CECT) images from The Cancer Genome Atlas and the Cancer Imaging Archive for prognosis analysis and radiomic model construction. The selection of optimal features was conducted using the intraclass correlation coefficient, minimum redundancy maximum relevance, and recursive feature elimination algorithms. A radiomic model for IDH1 prediction and radiomic score (RS) were established using a gradient-boosting machine. Associations between IDH1 expression, RS, clinicopathological variables, and overall survival (OS) were determined using univariate and multivariate Cox proportional hazards regression analyses and Kaplan-Meier curves.

RESULTS: IDH1 emerged as a distinct predictive factor in patients with HNSCC (hazard ratio [HR] 1.535, 95% confidence interval [CI]: 1.117-2.11, P = 0.008). The radiomic model, built on eight optimal features, demonstrated area under the curve values of 0.848 and 0.779 in the training and validation sets, respectively, for predicting IDH1 expression levels. Calibration and decision curve analyses validated the model's suitability and clinical utility. RS was significantly associated with OS (HR=2.22, 95% CI: 1.026-4.805, P = 0.043).

CONCLUSION: IDH1 expression is a significant prognostic marker. The developed radiomic model, derived from CECT features, offers a promising approach for diagnosing and prognosticating HNSCC.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Wang L, Peng J, Wen B, et al. Contrast-Enhanced Computed Tomography-Based Machine Learning Radiomics Predicts IDH1 Expression and Clinical Prognosis in Head and Neck Squamous Cell Carcinoma. Acad Radiol. 2024. PMID: 39256086. doi:10.1016/j.acra.2024.08.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。